http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109865127-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 |
| filingDate | 2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109865127-B |
| titleOfInvention | Use of modified thymosin beta 4 for the treatment of diabetic peripheral neuropathy |
| abstract | The present invention relates to the field of disease treatment. In particular, the invention relates to the use of modified thymosin beta 4 for the treatment of diabetic peripheral neuropathy in a subject (e.g. a human), and for the preparation of a medicament for the treatment of diabetic peripheral neuropathy in a subject (e.g. a human). The present invention also relates to a method of treating diabetic peripheral neuropathy comprising the step of administering the modified thymosin beta 4 to a subject in need thereof. |
| priorityDate | 2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.